Related references
Note: Only part of the references are listed.Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma
Hiroyoshi Nishikawa et al.
BLOOD (2012)
Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study
Takashi Ishida et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Phenotypical and functional specialization of FOXP3+ regulatory T cells
Daniel J. Campbell et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
Padmanee Sharma et al.
NATURE REVIEWS CANCER (2011)
Two Distinct Mechanisms of Augmented Antitumor Activity by Modulation of Immunostimulatory/Inhibitory Signals
Jun Mitsui et al.
CLINICAL CANCER RESEARCH (2010)
Induction of T cell anergy: integration of environmental cues and infectious tolerance
Pascal Chappert et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
FOXP3+ regulatory T cells in the human immune system
Shimon Sakaguchi et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Immune Therapy for Cancer
Michael Dougan et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
Makoto Miyara et al.
IMMUNITY (2009)
Human memory CCR4+CD8+ T cell subset has the ability to produce multiple cytokines
Takaaki Kondo et al.
INTERNATIONAL IMMUNOLOGY (2009)
Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3(+) regulatory T cells
Hyung W. Lim et al.
JOURNAL OF IMMUNOLOGY (2008)
IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity
Mary T. Litzinger et al.
BLOOD (2007)
Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor
Tomoyuki Yamaguchi et al.
IMMUNITY (2007)
Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice
Jeong M. Kim et al.
NATURE IMMUNOLOGY (2007)
Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation
Masao Matsuoka et al.
NATURE REVIEWS CANCER (2007)
CCR4 as a novel molecular target for immunotherapy of cancer
Takashi Ishida et al.
CANCER SCIENCE (2006)
In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines
Hiroyoshi Nishikawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Influence of CD4+CD25+ regulatory T cells on low/high-avidity CD4+ T cells following peptide vaccination
Hiroyoshi Nishikawa et al.
JOURNAL OF IMMUNOLOGY (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
E Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells
J Dannull et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells
K Ko et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients
H Nishikawa et al.
BLOOD (2005)
Definition of target antigens for naturally occurring CD4+ CD25+ regulatory T cells
H Nishikawa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Phenotypic and functional relationship between adult T-cell leukemia cells and regulatory T cells
Y Matsubara et al.
LEUKEMIA (2005)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
Naturally arising CD4(+) regulatory T cells for immunologic self-tolerance and negative control of immune responses
S Sakaguchi
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Cancer/testis antigens: an expanding family of targets for cancer immunotherapy
MJ Scanlan et al.
IMMUNOLOGICAL REVIEWS (2002)
Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells
O Yoshie et al.
BLOOD (2002)